Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS China to Overtake Japan as Second-Biggest Drug Market by 2016: IMS Health
July 18, 2012
-
ORGANIZATION 4.5 Bil. Yen Tax Hike Estimated in FY2012 Tax Reform: JPMA
July 17, 2012
-
BUSINESS RIJ Plans World’s First Trial of iPS Cell Therapy in Men: President & CEO Kagimoto
July 16, 2012
-
ORGANIZATION Wholesaler FTC to Make Serious Efforts for Improving “Services of Convenience”
July 13, 2012
-
BUSINESS Teijin Pharma to Boost New Drug Ratio to More than 50%, Prepare “Post-Feburic” Products: President Arao
July 12, 2012
-
BUSINESS Suzuken to Offer Voluntary Early Retirement Program for Record 500 Employees
July 11, 2012
-
REGULATORY Health Minister Komiyama Takes Lead to Include Reference Price Systems in Policy-Screening Group’s Proposals
July 10, 2012
-
REGULATORY On-Site Strategy Consultations to Be Held in Kansai Region: MHLW
July 6, 2012
-
BUSINESS Nippon Kayaku Considers Promotional Measures for Biosimilars, Vascular Embolization Medical Devices
July 5, 2012
-
BUSINESS AZ to Promote Symbicort, SMART Therapy Targeting GPs, Specialists
July 5, 2012
-
BUSINESS 230 MSs of Mediceo Begin to Work as ARs for Sawai
July 4, 2012
-
ORGANIZATION JGA Begins Posting Information on Out-of-Stock Products, Delayed Shipments on Website
July 3, 2012
-
BUSINESS Otsuka, Kyowa Kirin Announce Strategic Alliance in Fields of Diabetes, Oncology
July 2, 2012
-
REGULATORY JPO Rules Actonel Patent Invalid; Ajinomoto Considering Appeal
June 29, 2012
-
ACADEMIA Univ. of Tokyo Hospital’s New “Phase I Unit” to Initiate Trials for Takeda’s TAK-070 for AD
June 28, 2012
-
BUSINESS Eisai to Make Full-Scale Entry into Russian Market; Antiepileptic Agent Obtains Approval
June 28, 2012
-
REGULATORY MHLW Talks to Drug Makers with Facilities Eligible for Exemption from Planned Power Outages
June 27, 2012
-
REGULATORY MHLW Orders Updates from Chugai Following Criticism for Reporting Deficiencies by Roche in US
June 26, 2012
-
ORGANIZATION JPWA, NPhA Confirm Need for Thorough Efforts “at Ground Level” for Distribution Improvements
June 25, 2012
-
REGULATORY MHLW to Strengthen Focus on Dementia with Budget Request for FY2013
June 22, 2012
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s FY2026 drug pricing reform is set to usher in a new phase for the generics market, effectively bringing an…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…